iShares U.S. Pharmaceuticals ETF (IHE) is an ETF managed by BlackRock / iShares. Its largest position is JOHNSON & JOHNSON (JNJ), representing 23.03% of fund assets.
iShares U.S. Pharmaceuticals ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IHE
- Type:
- ETF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 22, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
JOHNSON & JOHNSON
|
23.03% | $230,416,966.08 | 942,632 |
|
-
ELI LILLY & Co
|
21.06% | $210,707,349.99 | 229,087 |
|
-
Merck & Co., Inc.
|
4.74% | $47,418,318.00 | 394,200 |
|
-
PFIZER INC
|
4.71% | $47,118,857.76 | 1,678,022 |
|
-
Royalty Pharma plc
|
4.70% | $47,065,861.44 | 981,152 |
|
-
BRISTOL MYERS SQUIBB CO
|
4.63% | $46,321,680.10 | 763,754 |
|
-
Zoetis Inc.
|
4.52% | $45,205,749.99 | 382,419 |
|
-
BLACKROCK FUNDS III
|
4.36% | $43,581,753.17 | 43,573,039 |
|
-
Viatris Inc
|
4.35% | $43,491,310.94 | 3,219,194 |
|
-
Elanco Animal Health Inc
|
3.32% | $33,232,332.83 | 1,388,731 |
|
-
Jazz Pharmaceuticals plc
|
3.21% | $32,107,873.90 | 169,838 |
|
-
Axsome Therapeutics, Inc.
|
2.00% | $20,005,038.18 | 118,359 |
|
-
TERNS PHARMACEUTICALS INC
|
1.27% | $12,675,416.88 | 240,429 |
|
-
LIGAND PHARMACEUTICALS INC
|
1.10% | $10,982,946.15 | 55,011 |
|
-
Indivior Pharmaceuticals, Inc.
|
1.06% | $10,636,514.16 | 348,967 |
|
-
CORCEPT THERAPEUTICS INC
|
1.05% | $10,547,514.60 | 261,660 |
|
-
CRINETICS PHARMACEUTICALS INC
|
1.04% | $10,406,406.40 | 286,520 |
|
-
SUPERNUS PHARMACEUTICALS, INC.
|
0.83% | $8,283,994.47 | 160,263 |
|
-
Prestige Consumer Healthcare Inc.
|
0.78% | $7,838,872.39 | 132,257 |
|
-
Tarsus Pharmaceuticals, Inc.
|
0.77% | $7,657,153.10 | 109,154 |
|
-
Liquidia Corp
|
0.72% | $7,249,476.60 | 192,090 |
|
-
Edgewise Therapeutics, Inc.
|
0.65% | $6,524,626.50 | 207,131 |
|
-
Amneal Pharmaceuticals, Inc.
|
0.59% | $5,897,637.24 | 474,468 |
|
-
NEKTAR THERAPEUTICS
|
0.56% | $5,626,777.80 | 78,204 |
|
-
Definium Therapeutics, Inc.
|
0.52% | $5,203,774.80 | 275,332 |
|
-
ALUMIS INC.
|
0.50% | $4,990,918.53 | 226,551 |
|
-
Enliven Therapeutics, Inc.
|
0.49% | $4,876,715.20 | 124,406 |
|
-
Innoviva, Inc.
|
0.46% | $4,625,749.00 | 198,530 |
|
-
Organon & Co.
|
0.43% | $4,352,645.48 | 726,652 |
|
-
PERRIGO Co plc
|
0.41% | $4,131,237.66 | 384,659 |
|
-
OCULAR THERAPEUTIX, INC
|
0.41% | $4,122,848.73 | 486,759 |
|
-
ANI PHARMACEUTICALS INC
|
0.39% | $3,863,994.30 | 50,247 |
|
-
Trevi Therapeutics, Inc.
|
0.35% | $3,463,350.58 | 290,306 |
|
-
HARROW, INC.
|
0.32% | $3,248,539.06 | 92,131 |
|
-
Amylyx Pharmaceuticals, Inc.
|
0.32% | $3,242,592.00 | 233,280 |
|
-
PHIBRO ANIMAL HEALTH CORP
|
0.32% | $3,188,289.64 | 57,644 |
|
-
Harmony Biosciences Holdings, Inc.
|
0.31% | $3,111,266.77 | 111,077 |
|
-
Wave Life Sciences, Inc.
|
0.29% | $2,929,478.50 | 404,066 |
|
-
COLLEGIUM PHARMACEUTICAL, INC
|
0.29% | $2,921,800.64 | 88,352 |
|
-
Nuvation Bio Inc.
|
0.29% | $2,869,130.55 | 668,795 |
|
-
EyePoint, Inc.
|
0.28% | $2,803,652.34 | 217,506 |
|
-
Xeris Biopharma Holdings, Inc.
|
0.27% | $2,689,796.40 | 463,758 |
|
-
Pacira BioSciences, Inc.
|
0.26% | $2,592,672.00 | 114,720 |
|
-
Rapport Therapeutics, Inc.
|
0.25% | $2,500,915.83 | 79,927 |
|
-
MBX Biosciences, Inc.
|
0.21% | $2,097,858.00 | 70,280 |
|
-
OMEROS CORP
|
0.21% | $2,092,622.40 | 198,165 |
|
-
Amphastar Pharmaceuticals, Inc.
|
0.19% | $1,937,353.05 | 98,895 |
|
-
ARVINAS, INC.
|
0.19% | $1,902,763.60 | 179,506 |
|
-
Maze Therapeutics, Inc.
|
0.18% | $1,766,433.45 | 59,177 |
|
-
Theravance Biopharma, Inc.
|
0.17% | $1,678,003.47 | 103,389 |
Advertisement (320x50)